Vanguard Portfolio Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.2M Buy
989,529
+138,096
+16% +$3.01M ﹤0.01% 1873
2026
Q1
$14.8M Buy
+851,433
New +$16.1M ﹤0.01% 2000

Other funds holding CDNA

Vanguard Portfolio Management's CDNA Position: Q2 2026 in Review

Vanguard Portfolio Management increased its CareDx (CDNA) stake by 16% in Q2 2026, buying an estimated $3.01M and bringing the position to 989,529 shares worth $28.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1873.

Vanguard Portfolio Management first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Vanguard Portfolio Management held 989,529 shares of CareDx worth $28.2M as of Q2 2026.
  • Vanguard Portfolio Management bought 138,096 CareDx shares in Q2 2026, an estimated $3.01M.
  • CareDx made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1873 holding.
  • Vanguard Portfolio Management first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
  • 225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.